Skip to main content
Article thumbnail
Location of Repository

Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen

By Li-Fang Wang, Jau-Shiuh Chen, Chih-Jung Hsu, Ching-Yi Liu, Jhang-Sian Yu and Shi-Chuen Miaw

Abstract

Exposure to protein allergen epicutaneously, inducing a Th2-dominant immune response, sensitizes the host to the development of atopic disease. Antigen-driven bystander effect demonstrates that polarized T cells could instruct naïve T cells to differentiate into T cells with similar phenotype. In this study, we aimed to determine the contribution of antigen-driven bystander effect on epicutaneous sensitization with a newly introduced protein allergen. BALB/c mice were immunized intraperitoneally with BSA emulsified in alum, known to induce a Th2 response, three weeks before given BSA and OVA epicutaneously. Lymph node cells from these mice restimulated with OVA secreted higher levels IL-4, IL-5 and IL-13 as compared with cells from mice without BSA immunization. In addition, BALB/c mice immunized subcutaneously with BSA emulsified in complete Freund's adjuvant, known to induce a Th1-predominant response, also induced higher Th1 as well as Th2 cytokine response when restimulated with OVA as compared with mice without immunization. We demonstrated that subcutaneous immunization with BSA in CFA induced Th2 as well as Th1 response. The threshold of epicutaneous sensitization to OVA was also reduced, possibly due to increased expressions of IL-4 and IL-10 in the draining lymph nodes during the early phase of sensitization. In conclusion, antigen-driven bystander effect, whether it is of Th1- or Th2-predominant nature, can accelerate epicutaneous sensitization by a newly introduced protein allergen. These results provide a possible explanation for mono- to poly-sensitization spread commonly observed in atopic children

Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2656495
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2003). Allergen penetration through the skin.
    2. (2006). Anto JM: Early-life domestic aeroallergen exposure and IgE sensitization at age 4 years. J Allergy Clin Immunol
    3. (2003). BM: Instruction of naive CD4+ T cells by polarized CD4+ T cells within dendritic cell clusters.
    4. (1995). C: Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen.
    5. (2002). Corey L: Expression of cutaneous lymphocyte-associated antigen by CD8+ T cells specific for a skin-tropic virus.
    6. (1999). CU: The HECA-452 epitope is highly expressed on lymph cells derived from human skin.
    7. (1999). DYM: Evidence for Superantigen Involvement in Skin Homing of T cells in Atopic Dermatitis.
    8. (2004). Educated' dendritic cells act as messengers from memory to naive T helper cells. Nat Immunol
    9. (2005). Geha RS: COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    10. (1998). Geha RS: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.
    11. (2004). Geha RS: The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.
    12. (1991). HL: Antigen-driven bystander suppression after oral administration of antigens.
    13. (1998). Imokawa G: Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response.
    14. (2000). Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis.
    15. (2003). K: IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen.
    16. (2004). K: IL4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. J Immunol
    17. (1999). Natural course of sensitization to food and inhalant allergens during the first 6 years of life.
    18. (2002). Ogg GS: Allergen-specific CD8+ T cells and atopic disease.
    19. (2003). Paller AS: Atopic dermatitis and the atopic march.
    20. (1999). PG: Development of allergen-specific T-cell memory in atopic and normal children. Lancet
    21. (2005). Recent Highlights in the pathophysiology of atopic eczema. Int Arch Allergy Appl Immunol
    22. (2005). Relationship between aeroallergen and food allergen sensitization in childhood. Clin Exp Allergy
    23. (1996). RH: Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice.
    24. (2003). Skin scratching switches immune responses from Th2 to Th1 type in epicutaneously immunized mice.
    25. (1993). Terstappen LWMM: Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyteassociated antigen, a tissue-selective homing receptor for skin-homing T cells.
    26. (2003). Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo.
    27. (2005). The environment and risk factors for atopy. Current allergy and asthma reports
    28. (2003). Tsitsikov E, Geha RS: IL10 is critical for Th2 responses in a murine model of allergic dermatitis.
    29. (2006). Yu H-S: Crosspriming with an epicutaneously introduced soluble protein antigen generates Tc1 cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.